The novel eIF4A inhibitor potently synergizes with BCL2 inhibitor in high grade B-cell lymphoma with MYC and BCL2 rearrangements through regulating UPR

被引:0
|
作者
Seol, So-Young
Park, Chung Hyun
Kim, Soo Jeong
Chung, Haerim
Cho, Hyunsoo
Kim, Jin Seok
Kim, Yu Ri
机构
关键词
D O I
10.1158/1538-7445.AM2024-7598
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7598
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Primary thyroid high-grade B-cell lymphoma with MYC and BCL2 rearrangements in Hashimoto's thyroiditis
    Tariq, Hamza
    Zahra, Urooj
    DIAGNOSTIC CYTOPATHOLOGY, 2022, 50 (02) : 84 - 85
  • [22] Detailed molecular analysis and evaluation of prognosis in cases with high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements
    Stengel, Anna
    Kern, Wolfgang
    Meggendorfer, Manja
    Haferlach, Torsten
    Haferlach, Claudia
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (05) : 951 - 954
  • [23] Burkitt Lymphoma and Other 8 High-Grade B-Cell Lymphomas with or without MYC, BCL2, and/or BCL6 Rearrangements
    Alsharif, Rami
    Dunleavy, Kieron
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 33 (04) : 587 - +
  • [24] Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma
    Kramer, MHH
    Hermans, J
    Wijburg, E
    Philippo, K
    Geelen, E
    van Krieken, JHJM
    de Jong, D
    Maartense, E
    Schuuring, E
    Kluin, PM
    BLOOD, 1998, 92 (09) : 3152 - 3162
  • [25] Impact of BCL2 Mutations to BCL2 Protein Expression in B-Cell Lymphoma
    Baik, Jeeyeon
    Isgor, Irem
    Aypar, Umut
    Dogan, Ahmet
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1096 - S1097
  • [26] Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements
    Sesques, Pierre
    Johnson, Nathalie A.
    BLOOD, 2017, 129 (03) : 280 - 288
  • [27] High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma
    Rosenthal, Allison
    Younes, Anas
    BLOOD REVIEWS, 2017, 31 (02) : 37 - 42
  • [28] Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements
    Evrard, Solene M.
    Pericart, Sarah
    Grand, David
    Amara, Nadia
    Escudie, Frederic
    Gilhodes, Julia
    Bories, Pierre
    Traverse-Glehen, Alexandra
    Dubois, Romain
    Brousset, Pierre
    Parrens, Marie
    Laurent, Camille
    HAEMATOLOGICA, 2019, 104 (04) : E154 - E157
  • [29] Interpreting MYC and BCL2 in diffuse large B-cell lymphoma
    Lai, Catherine
    Grant, Cliona
    Dunleavy, Kieron
    LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2091 - 2092
  • [30] Spontaneous Regression of High-Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements: Case Report and Literature Review
    Stanoszek, Lauren M.
    Smith, Lauren B.
    Grajewski, Karen
    Reneau, John C.
    Wilcox, Ryan
    Perry, Anamarija M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (02): : E120 - E125